INTRODUCTION
The hGH-V gene belongs to the GH gene family. These genes are located on chromosome 17 where they appear in the following order, from 5' to 3': GH-N, CS-L, CS-A, GH-V, CS-B (Owerbach et al., 1980; Barsh et al., 1983; Hirt et al., 1987; Chen et al., 1989) . The hGH-N gene is expressed in the pituitary gland and codes for human pituitary growth hormone (hGH). As a secreted product of the anterior pituitary, hGH promotes growth and development and is involved in regulating a variety of anabolic processes (Bolander, 1989) .
Pathological absence of hGH induces dwarfism or reduces statural growth, situations which can be corrected by administering exogenous hormone. During human pregnancy, production of maternal pituitary GH is progressively suppressed while placental GH (hPGH) is synthesized in the placenta (Hennen et al., 1985a (Hennen et al., ,b, 1986 Frankenne et al., 1988) and secreted continuously and in increasing amounts into the maternal bloodstream (Erikson et al., 1989) . hPGH contains the same total number of amino acids as hGH but differs at 13 positions and, moreover, exists in a minor, glycosylated form (Frankenne et al., 1990) . The hGH-V gene, which is expressed in the placenta, yields an 800-nucleotide mRNA (Igout et al., 1988) and a 1250-nucleotide mRNA resulting from alternative splicing (Cooke et al., 1988) . The 800-nucleotide mRNA codes for the 22 kDa hPGH. Specific expression of the hGH-V gene in the placenta has been demonstrated by in situ hybridization (Scippo et al., 1993) and by immunohistochemical localization (Jara et al., 1989) . The hGH-V cDNA coding for the major 22 kDa form has been isolated (Igout et al., 1988) .
hPGH has been purified from full-term placenta, but in (Ghrayeb et al., 1984) .
EXPERIMENTAL Materials
E. coli strain HB1O1 (Boyer and Rouland-Dussoix, 1969; Bolivar and Backman, 1979) was used as the bacterial host for cloning. Strain D1210 (Salder et al., 1980) bance at 600 nm reached 0.75, expression of the chimeric gene ompA-hGH-V was induced with 50 uM IPTG. The induction temperature was 30 or 37°C; aliquots (100 ml) were taken to monitor the time course of induction at each temperature. To produce large quantities of rec-hPGH, 30-litre batches of Lbroth medium were inoculated with 5 ml of overnight preculture. At an absorbance (600 nm) of 0.75, the temperature was reduced from 37°C to 30 'C. When the absorbance value reached 0.8 (600 nm), expression was induced with 50 ,#M IPTG. Proteins were released from the periplasm 9 h later by treating with lysozyme and EDTA to form spheroplasts as previously described by Koshland and Botstein (1980) and Osborn et al. (1972) . Cells were harvested at 4 'C by centrifuging for 15 min at 4000 g. All subsequent steps were carried out at 4 'C. Pellets corresponding to 7.5 litres of cell culture were suspended in 400 ml of a solution containing 0.1 M Tris/HCl (pH 7.2), 0.5 M sucrose and 0.5 mM EDTA, immediately followed by 40 ml of lysozyme (2 mg/ml) and 400 ml of cold distilled water. After addition of 1 ml of PMSF solution (1 mg/ml in ethanol), the suspension was incubated on ice and the efficiency of the spheroplasting procedure monitored by phase-contrast microscopy. Spheroplasts were stabilized by adding 22.5 ml of 1 M MgCl2. The spheroplasts were pelleted by centrifugation for 15 min at 4 'C at 4000 g. The pellet was resuspended in water, sonicated, and saved as a membrane/cytoplasm fraction.
Purification and analysis of rec-hPGH
The supernatant from the spheroplast treatment, which contained the periplasmic proteins, was mixed for 12 h with (NH4)2SO4 at 25 % saturation and the precipitate removed by centrifugation for 2 h at 4500 g. The (NH4)2SO4 concentration was brought to 60 % saturation for 16 additional hours. The 25-60 % (NH4)2SO4 precipitate was dissolved in. 60 ml of 50 mM NH4HCO3/NH3, pH 9.5, containing 1.6 M urea. The eluate was applied to a column of fast-flow Q-Sepharose. Proteins were eluted by raising the NH4HC03/NH3 concentration in the eluent from 50 to 600 mM. Aliquots of different eluted fractions were concentrated and analysed by SDS/PAGE. Fractions containing rec-hPGH were pooled and lyophilized. To prepare homogeneous rechPGH, the lyophilized fraction was subjected to gel filtration on a Sephacryl S200 HR 16/100 column and eluted with 150 mM NH4HCO3/NH3, pH 9.5.
SDS/PAGE analysis and Western blotting
Electrophoresis on 15 % (w/v) polyacrylamide gels in the presence of SDS was performed according to the method of Laemmli (1970) . The gels were stained with Coomassie Blue. Western blotting was performed according to Towbin et al. (1979) . Incubation with mAbs, and with antiserum, and staining were performed according to Frankenne et al. (1988) .
Isoelectrofocusing
A fraction enriched in rec-hPGH was applied to Immobiline (LKB) in the 7-10 pH range and focused according to Bjellquist and Ek (1982) . The gel was then cut into 0.5-cm fragments which were homogenized and eluted in 2 ml of distilled water. The pH was measured in each eluate. After centrifugation at 4500 g for 30 min, rec-hPGH was assayed in each fraction.
Amino-acid-sequence determinatlon and computer analysis
Rec-hPGH sequencing was carried out with a 477A pulsed-liquid sequencer according to the manufacturer's instructions (Applied Biosystems, Foster City, CA, U.S.A.).
The theoretical isoelectric point was calculated with the PC GENE program. Prediction of the prokaryotic secretory signal sequence of the ompA/hPGH hybrid was done according to von Heijne (1986) . The hydropathy profile was determined by the method of Kyte and Doolittle (1982) .
M.s. analysis
The molecular mass of rec-hPGH was determined with a BIO-Q triple quad electrospray-ionization mass spectrometer (Fisons Instruments, Altrincham, Cheshire, U.K.). Sample (100 pmol) was dissolved in 10 ,ul of methanol/water/acetic acid (99:99:2, by vol.), then injected into the electrospray with a Rheodyne 5717 injector. The sample was pumped at a flow rate of 4 ,u/min by a 140A solvent delivery system (Applied Biosystems, Foster City, CA, U.S.A.). The m/z values were scanned from 800 to 1600 Da for 9 s; scans were accumulated for 2.5 min. Measurements were calibrated with horse heart myoglobin (16951.5 Da).
RESULTS

Construction of pIPGH1
Plasmid pIN-III-ompA3 (Ghrayeb et al., 1984) was used as the starting material for constructing a rec-hPGH secretion vector.
This plasmid contains a hybrid Ipp/lacPO promoter and lacI gene. A foreign gene can be cloned into the EcoRI-BamHI multiple cloning site (Figure 1 ). To insert hGH-VcDNA into the pIN-III-ompA3 vector, we first removed a 90-bp fragment of this vector with XbaI and EcoRI endonucleases. After purification, the 90-bp fragment was digested with HhaI, yielding the 78-bp XbaI-HhaI sequence containing the 5' region coding for the signal peptide. From hGH-V cDNA, a 200-bp fragment was removed with ThaI endonuclease. A DNA duplex named A1, with the complementary HhaI site at its 5' end and the blunt-end site at the 3' end, was synthesized. The Al duplex was inserted between a 78-bp fragment of pIN-III-ompA3 (5' end) and the 606-bp fragment of hGH-V cDNA (3' end). The resulting sequence containing the coding region of the ompA signal peptide linked to the coding sequence of mature hPGH ( Figure  2 ) was inserted into the XbaI-EcoRI site of the pIN-III-ompA3 plasmid. The ligation mixture was used to transform E. coli D1210. The correct plasmid, when digested with XbaI and EcoRI, yielded two fragments (7.4 and 0.74 kb). The plasmids of nine positive colonies were analysed by Southern blotting with 5' 32P-labelled oligonucleotide Al. The junction between the ompA signal coding sequence and the hGH-V cDNA was checked by sequence analysis (Sanger et al., 1977) . Four positive colonies, each containing the correct plasmid (named pIPGH1), were tested for their capacity to produce, upon induction, soluble rechPGH in the periplasm. This was done by immunoassay detection of extracted rec-hPGH (Figure 3 ). All four colonies were found to produce soluble rec-hPGH. Plasmid pIPGH1 was used for further study. E. coli D 1210 harbouring pIPGH1 was grown and induced as described above.
Optimization of expression of the ompAlhGH-V gene in E. coli
We investigated the effects of time and temperature at a low IPTG concentration (50,M) on the expression of the ompA/hGH-V gene in E. coli. This preliminary study was performed in the Multigen convertible bench-top culture apparatus as described in the Experimental section. The concentrations of periplasmic rec-hPGH and total periplasmic protein were measured respectively by radioimmunoassay (Figure 3) and by the Bradford assay (Bradford, 1976 (Figure 4 ).
Extraction, purification and characterization of rec-hPGH
The induced cells were fractionated, yielding a membrane/ cytoplasmic fraction and a periplasmic fraction; 10% of the rec-hPGH remained in the membrane/cytoplasmic fraction. The rec-hPGH was purified from the periplasmic fraction as described in the Experimental section. In anion-exchange chromatography, rec-hPGH eluted between 23 % and 42 % NH4HCO3/NH3 (Figure 5a ). Its purity was as high as 70 %, as determined by SDS/PAGE (Figure 5b ). To obtain a homogeneous preparation, the eluted fraction containing rec-hPGH was subjected to gel filtration. As shown in Figure 6 , the rec- Figure 2 The primary structure of the ompA/hGH-V protein hPGH preparation appeared homogeneous and the apparent molecular mass of the protein was 22 kDa. We also purified a second form of rec-hPGH, with an apparent molecular mass of 24 kDa (Figure 6 ). This form dissociates under reducing conditions into two forms (5.7 and 16 kDa; data not shown). Figure 2 shows the complete nucleotide sequence of the ompA/hGH-V hybrid gene. By comparing the 5' portion of the sequence with the signal peptide cleavage site (von Heijne, 1986) , amino acid residue 22 (Phe) from the initiation site was tentatively assigned as the first N-terminal amino acid of the mature protein.
As determined by amino acid sequencing, the apparently 24 kDa and 22 kDa forms have the same primary structure. The former, however, is nicked between amino acids 141 and 142, owing to reduced form. Since rec-hPGH has been shown to exist in an oxidized form containing two disulphide bridges, we checked the molecular mass after addition of dithiothreitol. Figure 7 (b) clearly shows that this treatment increases the molecular mass by 4.2 Da. The immunoreactivity of rec-hPGH with 5B4 and K24 mAbs was compared with that of pituitary GH (Figure 3 ) and found to be similar to that of the natural product extracted from full-term placenta .
DISCUSSION
In preliminary experiments (Igout et al., 1989) we have demonstrated that the pIPGHl/E. coli D1210 system expresses rechPGH and transports it into the periplasm. However, rec-hPGH accounted for only 0.1 % of the total periplasmic protein. To avoid excessive expression of the chimeric gene and formation of inclusion bodies or rapid degradation of rec-hPGH, induction was performed at 30°C instead of 37°C and at low IPTG concentrations (e.g. 50 1sM). Loss of rec-hPGH by precipitation near its pI (8.24) was avoided by forming spheroplasts at pH 7.2 instead of pH 8 as described by Koshland and Botstein (1980) . Under these conditions, the relative rec-hPGH concentration increased 20-fold and the protein remained soluble, but the hGH-V cDNA expression remains significantly lower than that of hGH-N with the same expression system (Hsiung et al., 1986) . It had to be concentrated in 8 M urea, however, to avoid aggregation and precipitation.
The E. coli D1210/pIPGHl system also secreted, under nonoptimal conditions, a small amount of a second form with an a b c d e f apparent molecular mass of 24 kDa. This form was identical to the 22 kDa form but was cleaved between amino acids 141 and 142. The disulphide bond between Cys-53 and Cys-165 maintains the association of the two resulting peptides. This type of cleavage has previously been observed for human growth hormone extracted from the pituitary gland (Lewis et al., 1976) . Treatment with protease inhibitor (EDTA, PMSF and Trasylol) does not protect rec-hPGH from partial cleavage between amino acids 141 and 142. The ompA signal peptide was correctly processed: this sequence only has the ability to anchor the nascent polypeptide to the cytoplasmic membrane (Figure 2) .
The pl of rec-hPGH, both as calculated from the sequence and as experimentally determined, is 8.24 and not 9.3 as suggested by Cooke et al. (1988) . Preliminary experiments show that rec-hPGH binds to the hepatic GH receptor (Igout et al., 1991) , confirming its correct folding and potential somatogenic activity. Sufficient quantities of rec-hPGH are now available for exhaustive biological testing and pharmacological studies.
